White Papers

CMS' Proposed Change to Reimbursement for the Office/Outpatient Visit Codes Sets in 2019

Revised payment rates introduced in the Proposed 2019 Medicare Physician Fee Schedule would transform the payment landscape for evaluation and management (E/M) services rendered millions of times each year as CMS seeks to level reimbursement for these services.  If finalized, New Patient Office/Outpatient encounters reported with 99202 – 99205 will be reimbursed at $135 and code set 99212 – 99215 for Established Patients will be paid at $93.

According to the Proposed Rule, CMS states that these CPT codes and their current payment rates “no longer appropriately reflect the complete range of services and resource costs associated with furnishing E/M services to all patients across the different physician specialties.”  To standardize the pricing, CMS would simply apply the same relative value units to the level 2 – 5 codes.

Let’s look at how this would play-out against the current Medicare national payment rates in the non-facility setting:

Type of Encounter E/M Code National Non-Facility Rate 2018 Proposed Revised Rate
New Patient 99201 $45 $44
New Patient 99202 $76 $135
New Patient 99203 $110 $135
New Patient 99204 $167 $135
New Patient 99205 $211 $135
Established Patient 99211 $22 $24
Established Patient 99212 $45 $93
Established Patient 99213 $74 $93
Established Patient 99214 $109 $93
Established Patient 99215 $148 $93

Clearly the individual impact of this change would be dependent on a provider’s E/M billing profile but according to the final rule, “minimal change to overall payment” would expect to be seen for the majority of specialties.  The pushback from clinicians, however, would indicate that many believe otherwise.  In fact many specialties that CMS forecasts would set to gain from the change, such as Dermatology, have also opposed it.

In its August 2018 letter to CMS the AMA spoke on behalf of the 150 medical organizations that co-signed, stating their opposition to the proposed rule because it “could hurt physicians and other health care professionals in specialties that treat the sickest patients, as well as those who provide comprehensive primary care, ultimately jeopardizing patients’ access to care.”

As part of its proposal, CMS also addresses the long-running contention among providers that the amount of documentation required to support the higher-level E/M codes is an administrative burden that takes away from patient care.  According to current documentation guidelines the extent of  history-taking, examination and medical decision-making rendered (and documented) is be driven by the severity of the patient.  Thus, the more complex a patient, the more bullet points of data would be expected in the visit notes.

The proposed rule would offer clinicians unprecedented flexibility in documenting their patient encounters, such as allowing them to focus more on the elements of medical decision making or time spent rendering the service rather than the historical 3 key components.  Additionally, providers would only have to document to a level 2 E/M code even if the service rendered equated to a level 3, 4 or 5.

While the loosening of the rules is certainly tempting to providers who have worked for years with the 1995 and 1997 Documentation Guidelines, there is valid concern that unless the revised guidelines are adopted by the AMA’s CPT, providers could face significant risk of audit liability when it comes to the commercial carriers who still work from the traditional documentation policies.

This issue is not is not expected to be finalized until November, after CMS has reviewed and considered the feedback received from the provider community.  APS will continue to post relevant updates as they occur.

Recent White Papers

Q2 2020 CPT Codes Included in the Laboratory DOS Exception Policy for Designated ADLTs and Molecular Pathology Tests
May 28th, 2020
$20 Billion in Additional Provider Relief Funds Available Through Application
April 28th, 2020
MIPS 2020: Providers Can Earn Credit by Participating in COVID-19 Clinical Trials
April 23rd, 2020
Update: Guidance for Reporting Coronavirus Lab Tests
April 20th, 2020


APS has completely fulfilled all of our expectations, both in clinical pathology professional component billing and in all other areas of pathology billing.

Salt Lake City, UT

Are you ready to start seeing increased revenues? APS’ expertise and commitment to service can get you there.
Begin your partnership with APS Medical Billing.
Contact Us